Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.63 |
| ▸ | RAB9A | P51151 | 4/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.63 |
| ▸ | MGAM | O43451 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 6/20 | 0.61 |
| ▸ | KDM1A | O60341 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.55 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MIF | P14174 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL685220 | 0.90 | KDM1A (0.67) | KDM4ERAB9AMAPTALDH1A1BLM | |
| SCHEMBL12746373 | 0.89 | GUSB (0.65) | KDM4ERAB9AMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL13659855 | 0.88 | MGAM (0.61) | KDM4ERAB9AMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL7949337 | 0.88 | KMT2A (0.78) | KDM4ERAB9AMAPTALDH1A1BLM | |
| SCHEMBL7949340 | 0.88 | KMT2A (0.78) | KDM4ERAB9AMAPTALDH1A1BLM | |
| SCHEMBL683790 | 0.88 | MGAM (0.66) | KDM4ERAB9AMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL12746249 | 0.87 | KDM1A (0.69) | KDM4ERAB9AMAPTALDH1A1BLM | |
| SCHEMBL20750167 | 0.87 | MGAM (0.60) | KDM4ERAB9AMAPTALDH1A1BLM | |
| SCHEMBL6751418 | 0.86 | SIRT1 (0.72) | KDM4ERAB9ABLMSMN1; SMN2KMT2A | |
| SCHEMBL10049701 | 0.86 | SIRT1 (0.72) | KDM4ERAB9ABLMSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3524347-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (DE) | 2019-08-14 | — | — | EP | disclosed |
| EP-2271426-B1 | USE OF HYDRAZIDE COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (DE) | 2019-02-20 | — | — | EP | disclosed |
| US-8791298-B2 | Use of metal hydrazide complex compounds as oxidation catalysts | BASF SE (DE) | 2014-07-29 | — | — | US | disclosed |
| US-8791298-B2 | Use of metal hydrazide complex compounds as oxidation catalysts | BASF SE (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20130281353-A1 | Use of Metal Hydrazide Complex Compounds as Oxidation Catalysts | BASF SE (DE) | 2013-10-24 | — | — | US | disclosed |
| US-20130281353-A1 | Use of Metal Hydrazide Complex Compounds as Oxidation Catalysts | BASF SE (DE) | 2013-10-24 | — | — | US | disclosed |
| US-8492324-B2 | Use of metal hydrazide complex compounds as oxidation catalysts | BASF SE (DE) | 2013-07-23 | — | — | US | disclosed |
| US-8492324-B2 | Use of metal hydrazide complex compounds as oxidation catalysts | BASF SE (DE) | 2013-07-23 | — | — | US | disclosed |
| US-20120010075-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | DOW AGROSCIENCES LLC (US) | 2012-01-12 | — | — | US | disclosed |
| US-20120010075-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | DOW AGROSCIENCES LLC (US) | 2012-01-12 | — | — | US | disclosed |
| US-20110071066-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| US-20110071066-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| WO-2009124855-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | BASF SE (DE) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071066-A1 | USE OF METAL HYDRAZIDE COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | SOD1, H1-4, H1-5 | KDM4E 348/4885RAB9A 3542/4885MAPT 1770/4885 |
| US-20120010075-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | SOD1, CYP51A1, SOD3 | KDM4E 1473/4885RAB9A 3846/4885MAPT 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.